Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Anel

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Recent Patents on Inflammation & Allergy Drug Discovery|August 11, 2011
APO2L/TRAIL: new insights in the treatment of autoimmune disordersAlberto Anel, Luis Martinez-Lostao
Methods in Cell Biology|January 25, 2025
Human cancer cells xenografts to assess the efficacy of granulysin-based therapeuticsRaquel Ibáñez-Pérez, Alberto Anel
Cancer Cell|October 27, 2023
Mitochondrial control of antigen presentation in cancer cellsRuth Soler-Agesta, Alberto Anel, Lorenzo Galluzzi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
How Do Cytotoxic Lymphocytes Kill Cancer Cells?Luis Martínez-Lostao, Alberto Anel, Julián Pardo
Molecular Immunology|June 30, 2006
Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 lossAlberto Bosque, Isabel Marzo, Javier Naval, et al.
Biochemical Pharmacology|January 11, 2012
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancerLuis Martinez-Lostao, Isabel Marzo, Alberto Anel, et al.
Molecular Pharmacology|March 2, 2005
Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 eliminationMaría Gómez-Benito, Isabel Marzo, Alberto Anel, et al.
European Journal of Immunology|October 2, 2002
Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor controlJulián Pardo, Sandra Balkow, Alberto Anel, et al.
European Journal of Immunology|July 13, 2002
The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cellsJulián Pardo, Sandra Balkow, Alberto Anel, et al.
Trends in Cancer|May 28, 2020
Novel Forms of Immunomodulation for Cancer TherapyAlfonso Serrano-Del Valle, Javier Naval, Alberto Anel, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Recent Patents on Inflammation & Allergy Drug Discovery|August 11, 2011
APO2L/TRAIL: new insights in the treatment of autoimmune disordersAlberto Anel, Luis Martinez-Lostao
Methods in Cell Biology|January 25, 2025
Human cancer cells xenografts to assess the efficacy of granulysin-based therapeuticsRaquel Ibáñez-Pérez, Alberto Anel
Cancer Cell|October 27, 2023
Mitochondrial control of antigen presentation in cancer cellsRuth Soler-Agesta, Alberto Anel, Lorenzo Galluzzi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
How Do Cytotoxic Lymphocytes Kill Cancer Cells?Luis Martínez-Lostao, Alberto Anel, Julián Pardo
Molecular Immunology|June 30, 2006
Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 lossAlberto Bosque, Isabel Marzo, Javier Naval, et al.
Biochemical Pharmacology|January 11, 2012
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancerLuis Martinez-Lostao, Isabel Marzo, Alberto Anel, et al.
Molecular Pharmacology|March 2, 2005
Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 eliminationMaría Gómez-Benito, Isabel Marzo, Alberto Anel, et al.
European Journal of Immunology|October 2, 2002
Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor controlJulián Pardo, Sandra Balkow, Alberto Anel, et al.
European Journal of Immunology|July 13, 2002
The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cellsJulián Pardo, Sandra Balkow, Alberto Anel, et al.
Trends in Cancer|May 28, 2020
Novel Forms of Immunomodulation for Cancer TherapyAlfonso Serrano-Del Valle, Javier Naval, Alberto Anel, et al.
Pageof 10